Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Relapsed and Refractory Wilms Tumour and CCSK
NCT00025103Phase 2Unknown
- Sponsor
- Children's Cancer and Leukaemia Group
- Start
- May 2001
- Primary completion
- Nov 2008
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of vincristine, actinomycin D, doxorubicin, cyclophosphamide, etoposide in Wilms' tumor, clear cell sarcoma of the kidney (CCSK), sponsored by Children's Cancer and Leukaemia Group. Status: unknown.
02
Drugs
vincristineactinomycin Ddoxorubicincyclophosphamideetoposide
03
Conditions
Wilms' tumorclear cell sarcoma of the kidney (CCSK)
Beyond the preview
Go deeper on NCT00025103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025103.